Bleichroeder’s Kazia Therapeutics KZIA Stock Holding History
Bought
Maintained
Sold
Other funds holding KZIA
KCM
Bleichroeder's KZIA Position: Q3 2026 in Review
Bleichroeder increased its Kazia Therapeutics (KZIA) stake by 23% in Q3 2026, buying an estimated $1.13M and bringing the position to 490,410 shares worth $4.71M. The position accounts for 0.46% of the portfolio, ranked #47.
Bleichroeder first reported a position in KZIA in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.63M in Q2 2026. 34 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.
- Bleichroeder held 490,410 shares of Kazia Therapeutics worth $4.71M as of Q3 2026.
- Bleichroeder bought 90,410 Kazia Therapeutics shares in Q3 2026, an estimated $1.13M.
- Kazia Therapeutics made up 0.46% of Bleichroeder's portfolio in Q3 2026, its #47 holding.
- Bleichroeder first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Bleichroeder's Kazia Therapeutics position peaked at $5.63M in Q2 2026.
- 34 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.